Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mr. Seckman goes to Washington

This article was originally published in The Tan Sheet

Executive Summary

NNFA Executive Director & CEO David Seckman's lobbying efforts have targeted members of House Energy & Commerce Committee, which is investigating supplements including ephedra and andro. NNFA reports Seckman visited more than 30 Congressional offices in his first week in Washington, D.C. to educate members, staff on DSHEA and to promote message that FDA has sufficient authority to regulate supplements. Seckman also met with FDA Deputy Commissioner Lester Crawford, PhD, and others May 23 to discuss andro and other issues, such as FDA's authority under DSHEA. NNFA opened Washington office in April (1"The Tan Sheet" May 5, 2003, In Brief)...

You may also be interested in...



NNFA opens D.C. office

Trade group's Washington, D.C. office opened April 30 to "expand advocacy efforts with federal legislators and regulators on behalf of its members and the natural products industry." NNFA Executive Director & CEO David Seckman is first to relocate to the new office, "which will initially deal primarily with government relations and public affairs," group says. NNFA, which has been planning the move for more than a year, will evaluate its staffing needs as time goes on; group retains its Newport Beach, Calif. office. D.C. branch is located at 1220 19th St. NW, Suite 400...

Amgen To Buy Out Japan JV With Astellas

Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform for Otezla growth.

QUOTED. 23 January 2020. John Milad.

Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.

Topics

UsernamePublicRestriction

Register

PS095526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel